This is a past event. Registration is closed. View other Swedish Chamber of Commerce Singapore events.
Swedish Chamber of Commerce Singapore logoSwedish Chamber of Commerce China logoSwedish Chamber of Commerce in Hong Kong logoSwedish Australian Chamber of Commerce logoSwedish Chamber of Commerce Korea logoNordCham Indonesia (Nordic Chamber of Commerce in Indonesia) logoThe Swedish Chamber of Commerce and Industry in Japan logoNordcham Philippines logo

Event Details

This session will kick off a new SwedCham series called Recovery Sharp Talk which will focus on topics relevant to our current geopolitical as well as economic situation with regards to the pandemic. Free for SwedCham members!

As COVID-19 continues its spread around the world, pharmaceutical companies have been working day and night for their shared goal to develop a vaccine against the disease and end the pandemic.

AstraZeneca, a global pharmaceutical company combining Swedish and British innovation, is at the forefront of vaccine development. The company announced on 23 November that its vaccine is up to 90% effective. With this significant progress, AstraZeneca will hopefully soon be able to provide the world with a safe and reliable vaccine.

We are proud to welcome Alec van Gelder, Executive Director of International Government Affairs at AstraZeneca in Shanghai to SwedCham's APAC stage. In his presentation, Mr Van Gelder will cover AstraZeneca's journey and progress on vaccine development, unique insights from a pharmaceutical company operating in a pandemic world, and their determination to make the vaccine accessible for all at no profit during the pandemic.

Join us for this Recovery Sharp Talk session hosted by SwedCham Shanghai.


  • Alec van Gelder (Executive Director, International Government Affairs of AstraZeneca)

    Alec van Gelder

    Executive Director, International Government Affairs of AstraZeneca